Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
May 12, 2016 |
referred to health |
Senate Bill S7686
2015-2016 Legislative Session
Sponsored By
(R, C, IP) Senate District
Archive: Last Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
(R, C, IP, RFM) Senate District
2015-S7686 (ACTIVE) - Details
- See Assembly Version of this Bill:
- A10026
- Current Committee:
- Senate Health
- Law Section:
- Public Health Law
- Laws Affected:
- Add ยง278-a, Pub Health L
- Versions Introduced in 2017-2018 Legislative Session:
-
A2939
2015-S7686 (ACTIVE) - Sponsor Memo
BILL NUMBER: S7686 TITLE OF BILL : An act to amend the public health law, in relation to prescription drug cost transparency PURPOSE : The goal is analyze drug prices and underlying costs that drive drug pricing to inform the development of policies that will ensure access to affordable medications. By enhancing transparency in prescription drug pricing policymakers and purchasers can deliver on the promise of health care coverage and affordability. SUMMARY OF PROVISIONS : Amends the public health law by adding a new section 278-a, which provides the legislative intent that there should be reporting of drug costs and utilization of pharmaceutical drugs, which would be of use by policymakers, government agencies and others to understand pharmacy cost trends. This requires that each manufacturer of a brand and generic medication available in New York shall file a report on pharmaceutical costs when the Wholesale Acquisition Cost (WAC) of the drug exceeds one thousand dollars for a thirty day supply, or over a three month period the drug has a cumulative price increase of three
2015-S7686 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7686 I N S E N A T E May 12, 2016 ___________ Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to prescription drug cost transparency THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Legislative intent. It is the intent of the legislature to make information available to the public about the cost and utilization of pharmaceutical drugs. To fulfill this goal, the legislature finds that there should be annual reporting of drug costs and use that would be of use by policymakers, government agencies and others to understand pharmacy cost trends. S 2. The public health law is amended by adding a new section 278-a to read as follows: S 278-A. PRESCRIPTION DRUG COST TRANSPARENCY. 1. EACH MANUFACTURER OF A BRAND AND GENERIC MEDICATION THAT IS MADE AVAILABLE IN NEW YORK STATE SHALL FILE A REPORT ON PHARMACEUTICAL COSTS AS OUTLINED IN THIS SECTION. 2. THE MANUFACTURER OF A PHARMACEUTICAL DRUG THAT HAS A WHOLESALE ACQUISITION COST OF ONE THOUSAND DOLLARS FOR A THIRTY DAY SUPPLY SHALL FILE A REPORT PURSUANT TO THIS SECTION ON THE COSTS FOR EACH QUALIFYING DRUG. WHOLESALE ACQUISITION COST SHALL HAVE THE SAME MEANING AS FOUND IN SUBSECTION (C) OF 42 U.S. CODE SECTION 1395W-3A. 3. THE MANUFACTURER OF A PHARMACEUTICAL DRUG WHICH DURING A THREE MONTH PERIOD HAS A CUMULATIVE PRICE INCREASE OF THREE TIMES THE CONSUMER PRICE INDEX SHALL FILE A REPORT PURSUANT TO THIS SECTION ON THE COSTS FOR EACH QUALIFYING DRUG. 4. THE REPORT SHALL INCLUDE THE FOLLOWING FOR EACH DRUG DESCRIBED IN SUBDIVISIONS TWO AND THREE OF THIS SUBDIVISION: (A) THE TOTAL COSTS FOR THE PRODUCTION OF THE DRUG INCLUDING ALL OF THE FOLLOWING: (1) THE TOTAL RESEARCH AND DEVELOPMENT COSTS INCLUDING BUT NOT LIMITED TO: EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD15199-01-6
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.